3-((4-(2-Butyl-1-(4-(4-chlorophenoxy)phenyl)-1H-imidazole-4-yl)piperidin-1-yl)methyl)-1H-indole-5-carbonitrile

ID: ALA5194592

Chembl Id: CHEMBL5194592

PubChem CID: 163216003

Max Phase: Preclinical

Molecular Formula: C34H34ClN5O

Molecular Weight: 564.13

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc(C2CCN(Cc3c[nH]c4ccc(C#N)cc34)CC2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1

Standard InChI:  InChI=1S/C34H34ClN5O/c1-2-3-4-34-38-33(23-40(34)28-8-12-30(13-9-28)41-29-10-6-27(35)7-11-29)25-15-17-39(18-16-25)22-26-21-37-32-14-5-24(20-36)19-31(26)32/h5-14,19,21,23,25,37H,2-4,15-18,22H2,1H3

Standard InChI Key:  OWLMRISRKJELDA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5194592

    ---

Associated Targets(Human)

AGER Tchem Advanced glycosylation end product-specific receptor (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 564.13Molecular Weight (Monoisotopic): 563.2452AlogP: 8.39#Rotatable Bonds: 9
Polar Surface Area: 69.87Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.63CX LogP: 7.85CX LogD: 6.59
Aromatic Rings: 5Heavy Atoms: 41QED Weighted: 0.20Np Likeness Score: -1.25

References

1. Zhang C, Wang L, Xu Y, Huang Y, Huang J, Zhu J, Wang W, Li W, Sun A, Li X, Zhang H, Li J..  (2022)  Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression.,  236  [PMID:35430560] [10.1016/j.ejmech.2022.114347]

Source